Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Positive Regulator Molecules02:39

Positive Regulator Molecules

5.7K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.7K
The Cell Cycle Control System01:28

The Cell Cycle Control System

3.4K
The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
3.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

35.9K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.9K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

3.3K
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.3K
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 腫瘍学とがん発生
  5. 分子標的
  6. Cdk4/6の分解を調節することによってg1細胞サイクルを光化学的に制御する

CDK4/6の分解を調節することによってG1細胞サイクルを光化学的に制御する

Tianyi Wang1,2,3,4, Yaming Zhang2,3,4, Yuwei Liu2,3,4

  • 1Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou 510060, China.

iScience
|September 2, 2025

関連する実験動画

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

27.6K
Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

60.6K
Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization
08:52

Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization

Published on: August 16, 2015

19.5K

PubMed で要約を見る

まとめ
この要約は機械生成です。

癌細胞の分裂を制御する 光で活性化するシステムを開発しました この光化学的戦略はCDK4/6タンパク質を正確に分解し,副作用を少なくして標的を絞ったがん治療を提供します.

科学分野:

  • 生物化学
  • 分子生物学
  • 癌 研究

背景:

  • 癌の進行には,細胞周期,特にG1/S段階の変異が伴うが,これはしばしばCDK4/6依存Rbタンパク質のリン酸化によって引き起こされる.
  • 現在のCDK4/6降解剤は抗腫瘍的可能性を示しているが,正確な空間的および時間的な制御はなく,有害な効果をもたらしている.

研究 の 目的:

  • CDK4/6の分解剤の空間時間的制御のための光化学的戦略を開発する.
  • 標的がん治療のための光誘発によるCDK4/ 6タンパク質の分解を調査する.

主な方法:

  • 光化学的アプローチを用いて,光移動可能な保護グループでCRBNリガンドをケージ化します.
  • ユビキチン- プロテアゾーム系を通じて,光分裂とCDK4/ 6の降解を誘発するために365nmの光照射を使用します.

主要な成果:

  • CDK4/ 6タンパク質の光誘発的時空分解が達成された.
  • 空間と時間の制御でG1段階の細胞サイクル停止を証明した.
  • 現在の治療法と比較して 標的外効果の減少を示した.

結論:

  • 開発された光制御システムは,CDK4 / 6の正確な空間時間分解を可能にします.
キーワード:
生物化学癌について細胞生物学

関連する実験動画

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

27.6K
Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

60.6K
Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization
08:52

Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization

Published on: August 16, 2015

19.5K
  • この戦略は,がん治療と基礎生物学的研究における応用の特異性を高めます.